NanoViricides Says NV-387 Ebola Trial Is Progressing Well
NanoViricides said its Phase II trial of NV-387 oral gummies as an Ebola treatment is progressing well.
Story updates
12:51:20 PM UTC
SquawkNews
Phase II Clinical Trial of NV-387 Oral Gummies as Treatment of Ebola Progressing Well, Says NanoViricides